The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-9.0% to $775.00
Predicted High$862.00at 1 month
Predicted Low$775.00at 6 months
Max Drawdown (predicted)-9.0%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 16, 2026 12:39 am
Bear
ARGX trends lower to
$775.00
(-9.0% from $851.29)
by Feb 2027.
ride-then-fade
ThesisARGX trades well above DCF and composite fair value but momentum, visionary-founder narrative, and consistent EPS beats sustain the premium near term; over 6 months value gravity and rate pressure drag price modestly lower toward the deterministic baseline without full mean reversion.
Invalidated ifA break above $920 on positive catalyst or below $720 on pipeline setback would falsify this glide path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $851.29 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 16, 2026
—
$851.29at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 30, 2026
$785.59–$916.99typical range · internal point $858.00
—
±7.7%
6/10
Risk-on regime and momentum extend recent bid
1 month
Sep 16, 2026
$756.08–$946.50typical range · internal point $862.00
—
±11.2%
5/10
Narrative tailwind persists, no catalyst yet
2 months
Oct 16, 2026
$845.00
—
-0.7%
5/10
Valuation gravity begins to weigh modestly
3 months
Nov 16, 2026
$825.00
—
-3.1%
5/10
Premium compression as rate pressure lingers
4 months
Dec 16, 2026
$805.00
—
-5.4%
4/10
Year-end rebalancing trims extended winners
5 months
Jan 16, 2027
$785.00
—
-7.8%
4/10
Drift toward deterministic baseline continues
6 months
Feb 16, 2027
$775.00
—
-9.0%
4/10
Path converges near baseline endpoint
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$769.79
(-9.6%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.